Arbel D. Tadmor
- Immunology top 2%
- Immunotherapy and Immune Responses 5
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 4
-
- vaccines and immunoinformatics approaches 2
- RNA and protein synthesis mechanisms 2
- Genomics and Phylogenetic Studies 2
-
- Cancer Genomics and Diagnostics 3
- Biotechnology top 10%
-
- Bacteriophages and microbial interactions 3
-
- Genomics and Rare Diseases 1
- Co-authors
- Uğur ŞahinSebastian BoegelÖzlem TüreciSebastian KreiterMustafa DikenJohn C. CastleMartin LöwerBarbara Schrörs
- Cited by
- ImmunologyOncologyMolecular Biology
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Arbel D. Tadmor
12 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Immunology 979
- Oncology 835
- Molecular Biology 675
- Cancer Research 112
- Biotechnology 52
Countries citing papers authored by Arbel D. Tadmor
This map shows the geographic impact of Arbel D. Tadmor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arbel D. Tadmor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arbel D. Tadmor more than expected).
Fields of papers citing papers by Arbel D. Tadmor
This network shows the impact of papers produced by Arbel D. Tadmor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arbel D. Tadmor. The network helps show where Arbel D. Tadmor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arbel D. Tadmor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2021 | 3 | |
| 3 | 2020 | 141 | |
| 4 | 2018 | 38 | |
| 5 | 2016 | 1 | |
| 6 | Mutant MHC class II epitopes drive therapeutic immune responses to cancerbreakdown → | 2015 | 915 |
| 7 | 2014 | 280 | |
| 8 | 2014 | 33 | |
| 9 | 2012 | 10 | |
| 10 | 2011 | 176 | |
| 11 | 2008 | 29 | |
| 12 | 1968 | 5 |
About Arbel D. Tadmor
Arbel D. Tadmor is a scholar working on Cancer Research, Immunology and Virology, having authored 12 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Bacteriophages and microbial interactions (3 papers), Cancer Genomics and Diagnostics (3 papers), vaccines and immunoinformatics approaches (2 papers), RNA and protein synthesis mechanisms (2 papers), Genomics and Phylogenetic Studies (2 papers) and Genomics and Rare Diseases (1 paper). The work is most often cited by research in Immunology (979 citations), Oncology (835 citations) and Molecular Biology (675 citations). Arbel D. Tadmor has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Uğur Şahin, Sebastian Boegel, Özlem Türeci, Sebastian Kreiter, Mustafa Diken, John C. Castle, Martin Löwer, Barbara Schrörs, Mathias Vormehr and Fulvia Vascotto. Their work appears in journals such as Nature, Science and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.